Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.006 EUR
−5.44 M EUR
10.58 K EUR
684.59 M
About AROVELLA THERAPEUTICS LIMITED
Sector
CEO
Michael Baker
Headquarters
Carlton South
Website
Founded
1999
ISIN
AU0000182784
FIGI
BBG000QX7H12
Arovella Therapeutics Ltd. engages in the development invariant Natural Killer (iNKT) cell platform for treatment of cancer. Its technologies include iNKT cell therapy, CAR19-iNKT + CF33-CD19, CLDN18.2-iNKT, and DKK1-CAR-iNKT. The company was founded on December 21, 1999 and is headquartered in Carlton South, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange AROVELLA THERAPEUTICS stocks are traded under the ticker E4NA.
We've gathered analysts' opinions on AROVELLA THERAPEUTICS future price: according to them, E4NA price has a max estimate of 0.20 EUR and a min estimate of 0.20 EUR. Watch E4NA chart and read a more detailed AROVELLA THERAPEUTICS stock forecast: see what analysts think of AROVELLA THERAPEUTICS and suggest that you do with its stocks.
E4NA reached its all-time high on Nov 11, 2024 with the price of 0.128 EUR, and its all-time low was 0.007 EUR and was reached on Dec 27, 2021. View more price dynamics on E4NA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track AROVELLA THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
AROVELLA THERAPEUTICS is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
E4NA net income for the last half-year is −2.99 M EUR, while the previous report showed −2.43 M EUR of net income which accounts for −22.75% change. Track more AROVELLA THERAPEUTICS financial stats to get the full picture.
No, E4NA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AROVELLA THERAPEUTICS EBITDA is −6.85 M EUR, and current EBITDA margin is −63.34 K%. See more stats in AROVELLA THERAPEUTICS financial statements.
Like other stocks, E4NA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AROVELLA THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.